http://www.zibb.com/all/theme/cq/BioSante+Pharmaceuticals,+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 17 Nov 2009 08:01:51 GMTTue, 17 Nov 2009 08:01:51 GMT608831http://www.zibb.com/all/theme/cq/BioSante+Pharmaceuticals,+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5674372/BioSante+Pharmaceuticals+to+Present+at+the+Lazard+Capital+Markets+Annual+Healthcare+ConferenceBioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Phillip B. Donenberg, its CFO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel(R) (testosterone gel) update at the Lazard Capital Markets 6th Annualhttp://www.zibb.com/article/5674372/BioSante+Pharmaceuticals+to+Present+at+the+Lazard+Capital+Markets+Annual+Healthcare+ConferenceBioSante Pharmaceuticals, IncorporatedTue, 17 Nov 2009 08:01:51 GMThttp://www.newratings.com/en/main/company_headline.m?id=1987839NEW YORK, November 9 (newratings.com) - Analysts at Rodman & Renshaw initiate coverage of Biosante Pharmaceuticals Inc (ticker: BPAX) with a "market outperform" rating. The target price is set to $4. [more]http://www.newratings.com/en/main/company_headline.m?id=1987839BioSante Pharmaceuticals, IncorporatedMon, 09 Nov 2009 15:49:38 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3548510&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3548510&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2298534813%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3548510&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3548510&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2298534813%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSante Pharmaceuticals, IncorporatedThu, 29 Oct 2009 20:18:11 GMThttp://seekingalpha.com/article/167782-transformative-times-for-biosante-pharmaceuticals?source=feedThe last 75 days have been transformative for BioSante, Bill Milling, Sr. Dir Operations for BioSante Pharmaceuticals, Inc. (BPAX) told <ahttp://seekingalpha.com/article/167782-transformative-times-for-biosante-pharmaceuticals?source=feedBioSante Pharmaceuticals, IncorporatedWed, 21 Oct 2009 09:09:08 GMThttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-1483659738.html?x=0&.v=1LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX - News) today announced the closing of the sale, directly to threehttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-1483659738.html?x=0&.v=1BioSante Pharmaceuticals, IncorporatedFri, 14 Aug 2009 20:34:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=147563&full=1LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--A study to be published in the July 2009 issue of The Journal of Sexual Medicine reports that U.S. physicians wrote two million prescriptions a year for testosterone in 2006 and 2007, representing a significant increase since 2004. Importantly, 21% of thehttp://www.biospace.com/news_story.aspx?StoryID=147563&full=1BioSante Pharmaceuticals, IncorporatedThu, 25 Jun 2009 12:00:00 GMThttp://www.pharmaceutical-business-review.com/news/biosante_pharmaceuticals_files_nda_for_elestrin_in_israel_090623Elestrin to be used for the treatment of vasomotor symptoms associated with menopausehttp://www.pharmaceutical-business-review.com/news/biosante_pharmaceuticals_files_nda_for_elestrin_in_israel_090623BioSante Pharmaceuticals, IncorporatedTue, 23 Jun 2009 00:00:00 GMThttp://biz.yahoo.com/bw/081216/20081216005295.html?.v=1BioSante Pharmaceuticals Secures Committed Equity Financing Facility. - LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX - News) announced today that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited in whichhttp://biz.yahoo.com/bw/081216/20081216005295.html?.v=1BioSante Pharmaceuticals, IncorporatedTue, 16 Dec 2008 13:00:00 GMThttp://www.pharmpro.com/ShowPR~PUBCODE~021~ACCT~0000100~ISSUE~0808~RELTYPE~PR~ORIGRELTYPE~IN~PRODCODE~0000~PRODLETT~W.htmlBioSante Pharmaceuticals, Inc. has reacquired Elestrin (estradiol gel) from Nycomed US who in February 2008 acquired Bradley Pharmaceuticals, Inc., BioSante’s previous licensee of Elestrin. BioSante will immediately assume all manufacturing, distribution and marketing responsibilities for Elestrin.http://www.pharmpro.com/ShowPR~PUBCODE~021~ACCT~0000100~ISSUE~0808~RELTYPE~PR~ORIGRELTYPE~IN~PRODCODE~0000~PRODLETT~W.htmlBioSante Pharmaceuticals, Incorporatedhttp://topics.nytimes.com/top/news/business/companies/biosante-pharmaceuticals-inc/index.htmlGet Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics Business All NYT New York Times Business World U.S. N.Y. / Region Business Media & Advertising World Business Small Business Your Money DealBook Markets Research Mutual Funds My Portfolio Alertshttp://topics.nytimes.com/top/news/business/companies/biosante-pharmaceuticals-inc/index.htmlBioSante Pharmaceuticals, Incorporatedhttp://www.nsti.org/press/PRshow.html?id=243What: BioSante Pharmaceuticals, Inc. (AMEX: BPA) will give a presentation at Informed Investors Biotechnology / Healthcare / Pharmaceuticals On-line Investors Forum. The keynote presentation will be from Dr. Adam K. Noah, Research Analyst with Granite Financial Grouphttp://www.nsti.org/press/PRshow.html?id=243BioSante Pharmaceuticals, Incorporatedhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2007-07-25/420725200727VW.htmlJuly 25th, 2007 Data detailed in "A novel alphavirus vaccine A substance or group of substances meant to cause the immune system to respond to a tumor or to microorganisms, such as bacteria or viruses. A vaccine can help the body recognize and destroy cancer cells or microorganisms.http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-07-25/420725200727VW.htmlBioSante Pharmaceuticals, Incorporatedhttp://www.zibb.com/article/5659325/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 3/16/2010 - After Market Earnings Quarter: Q4 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5659325/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedTue, 10 Nov 2009 20:48:24 GMThttp://www.zibb.com/article/5656998/BioSante+Pharmaceuticals+to+Present+at+Merriman+Curhan+Ford+s+Investor+SummitBioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Phillip B. Donenberg, its CFO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel(R) (testosterone gel) update at Merriman Curhan Ford's 6th Annual Investorhttp://www.zibb.com/article/5656998/BioSante+Pharmaceuticals+to+Present+at+Merriman+Curhan+Ford+s+Investor+SummitBioSante Pharmaceuticals, IncorporatedTue, 10 Nov 2009 08:00:16 GMThttp://www.zibb.com/article/5636856/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5636856/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedMon, 02 Nov 2009 20:42:32 GMThttp://www.zibb.com/article/5502024/BioSante+Pharmaceuticals+to+Present+at+Upcoming+Healthcare+ConferencesBioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO will present an overview of the company and its impending merger with Cell Genesys (NASDAQ: CEGE) at two healthcare investment and partnering conferences during the month of September. Thehttp://www.zibb.com/article/5502024/BioSante+Pharmaceuticals+to+Present+at+Upcoming+Healthcare+ConferencesBioSante Pharmaceuticals, IncorporatedWed, 02 Sep 2009 17:03:00 GMThttp://www.zibb.com/article/5627624/BioSante+Pharmaceuticals+to+Present+at+the+Oppenheimer+Health+Care+ConferenceBioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel(R) (testosterone gel) update at the Oppenheimer 20th Annualhttp://www.zibb.com/article/5627624/BioSante+Pharmaceuticals+to+Present+at+the+Oppenheimer+Health+Care+ConferenceBioSante Pharmaceuticals, IncorporatedThu, 29 Oct 2009 08:00:16 GMThttp://www.zibb.com/article/5626132/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5626132/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedWed, 28 Oct 2009 20:51:27 GMThttp://www.zibb.com/article/5611601/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5611601/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedThu, 22 Oct 2009 20:49:05 GMThttp://www.zibb.com/article/5579226/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/10/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5579226/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedThu, 08 Oct 2009 20:49:10 GMThttp://www.zibb.com/article/5505016/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/10/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5505016/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedThu, 03 Sep 2009 20:43:25 GMThttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-to-bw-1177785347.html?x=0&.v=1LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX - News) today announced that it has received commitments from three institutional investorshttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-to-bw-1177785347.html?x=0&.v=1BioSante Pharmaceuticals, IncorporatedThu, 13 Aug 2009 18:16:00 GMThttp://www.zibb.com/article/5640718/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5640718/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedTue, 03 Nov 2009 20:49:49 GMThttp://www.zibb.com/article/5622202/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5622202/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedTue, 27 Oct 2009 20:49:24 GMThttp://www.zibb.com/article/5607917/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals Inc. (BPAX) Expected next earnings release: Announcement date: 11/9/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5607917/BioSante+Pharmaceuticals+Inc+BPAX+Corporate+Event+Announcement+NoticeBioSante Pharmaceuticals, IncorporatedWed, 21 Oct 2009 20:48:25 GMT